$9.26
arrow_drop_down3.34%Key Stats | |
---|---|
Open | $9.51 |
Prev. Close | $9.50 |
EPS | 1.16 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $46.35M |
LOW | HIGH | |
---|---|---|
Day Range | 9.35 | 9.64 |
52 Week Range | 7.11 | 10.04 |
Ratios | |
---|---|
EBITDA Margin % | - |
EPS | 1.16 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Daxor Corporation Awarded New U.S. Defense Health Agency - GlobeNewswire
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023